Stem-cell biology and gene editing advances offer hope for kidney regeneration, drug discovery
Mini-kidney organoids have now been grown in a laboratory by using genome editing to re-create human kidney disease in petri dishes.
The achievement, believed to be the first of its kind, resulted from combining stem cell biology with leading-edge gene-editing techniques.
The journal Nature Communications reports the findings today, Oct. 23. The work paves the way for personalized drug discovery for kidney disease.
The mini-kidney organoids were grown from pluripotent stem cells. These are human cells that have turned back the clock to a time when they could develop into any type of organ in the body. When treated with a chemical cocktail, these stem cells matured into structures that resemble miniature kidneys.
These organoids contain tubules, filtering cells and blood vessel cells. They transport chemicals and respond to toxic injury in ways that are similar to kidney tubules in people.
“A major unanswered question was whether we could re-create human kidney disease in a lab petri dish using this technology,” said Benjamin Freedman, who led the studies at Brigham and Women’s Hospital in Boston. He is now an assistant professor of medicine in the Division of Nephrology at the University of Washington and a UW Medicine researcher.
“Answering this question,” he said, “was important for understanding the potential of mini-kidneys for clinical kidney regeneration and drug discovery.”
To re-create human disease, Freedman and his colleagues used the gene-editing technique called CRISPR. They engineered mini-kidneys with genetic changes linked to two common kidney diseases, polycystic kidney disease and glomerulonephritis.
The organoids developed characteristics of these diseases. Those with mutations in polycystic kidney disease genes formed balloon like, fluid filled sacks, called cysts, from kidney tubules. The organoids with mutations in podocalyxin, a gene linked to glomerulonephritis, lost connections between filtering cells.
“Mutation of a single gene results in changes kidney structures associated with human disease, thereby allowing better understand of the disease and serving as models to develop therapeutic agents to treat these diseases,” explained Joseph Bonventre, senior author of the study. He is chief of the Renal Division at Brigham and Women’s Hospital and a principal faculty member at Harvard Stem Cell Institute.
“These genetically engineered mini-kidneys,” Freedman added, “have taught us that human disease boils down to simple components that can be re-created in a petri dish. This provides us with faster, better ways to perform ‘clinical trials in a dish’ to test drugs and therapies that might work in humans.”
The researchers found that genetically matched kidney organoids without disease-linked mutations showed no signs of either disease.
“CRISPR can be used to correct gene mutations,” explained Freedman. “Our findings suggest that gene correction using CRISPR may be a promising therapeutic strategy.”
The Latest on: Organoids
via Google News
The Latest on: Organoids
- Cyber Organoids Let Scientists Observe Cell Developmenton August 12, 2019 at 9:04 am
Scientists have successfully grown a ‘cyber organoid,’ a simplified organ formed from stem cells with integrated electrochemical sensors to observe its development. Organs are formed by the ...
- Prellis raises $10.5m to advance 3D tissue printingon August 12, 2019 at 7:58 am
Prellis advances its goal of using 3D holographic printing to create organoids for research and development – recently closing a $10.5m investment round to further develop its technology, which ...
- Cyborg organoids with built-in sensors will watch our brains growon August 12, 2019 at 7:44 am
6 companies hiring in fintech right now 7 US companies hiring in Ireland right now 7 of the coolest science jobs in the world Thinking about a career in marketing? An analytical mind is helpful ...
- Seeking origins of schizophrenia, autism by putting ‘stress’ on mini-placenta, mini-brainson August 12, 2019 at 6:42 am
Biologist Jennifer Erwin of the Lieber Institute for Brain Development, however, has no intention of babying her organoids: the world’s first human placentas in a dish that were made from stem ...
- Cyborg organoids reveal early stages of organ developmenton August 12, 2019 at 3:20 am
In research that reveals the early stages of organ development, researchers have integrated stretchable mesh nanoelectronics with 2D cells to form a 3D organoid structure. (Image: Harvard SEAS) These ...
- Harvard team grows cyborg mini-organs out of stem cellson August 11, 2019 at 11:28 pm
Now, researchers from Harvard have developed a way to create "cyborg organoids" by integrating nanoelectronics into cell cultures. But it can be hard to study these miniature, 3D versions of ...
- Science Writing Prize 2019 – Made-to-order cancer treatmentson August 11, 2019 at 5:06 pm
As just one example, scientists have recently discovered the use of organoids, lab-grown mini tumours, to help design individualised cancer treatment plans. Cancer is frightening and is often seen to ...
- Cyborg organoids offer a rare glimpse into the early stages of organ developmenton August 9, 2019 at 9:21 am
(Nanowerk News) What happens in the early days of organ development? How do a small group of cells organize to become a heart, a brain, or a kidney? This critical period of development has long ...
- Cyborg organoids offer rare view into early stages of developmenton August 9, 2019 at 6:14 am
What happens in the early days of organ development? How do a small group of cells organize to become a heart, a brain, or a kidney? This critical period of development has long remained the black ...
- Eloxx Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results and Provides Business Updateon August 7, 2019 at 5:30 am
We believe that the positive data we have generated for ELX-02 in cystic fibrosis patient-derived organoids substantially de-risk our Phase 2 program," said Robert E. Ward, Chairman and CEO of Eloxx ...
via Bing News